| Symbol | BTMD |
|---|---|
| Name | BIOTE CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 1875 W. WALNUT HILL LN,SUITE 100, IRVING, Texas, 75038, United States |
| Telephone | 972-486-9346 |
| Fax | — |
| — | |
| Website | https://www.biote.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001819253 |
| Description | Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - biote Corp. <b>Filed:</b> 2026-07-27 <b>AccNo:</b> 0002012383-26-002270 <b>Size:</b> 10 KB
Read moreBiote Schedules Second Quarter 2026 Financial Results Release and Conference Call
Read morePeterson Robert Charles 🟢 acquired 206.7K shares (1 derivative) of biote Corp. (BTMD) at $2.46 Transaction Date: Jun 12, 2026 | Filing ID: 000004
Read moreChristensen Bret 🟢 acquired 130.0K shares (1 derivative) of biote Corp. (BTMD) at $2.34 Transaction Date: Jun 08, 2026 | Filing ID: 000004
Read moreBeer Marc D 🟢 acquired 114.2K shares (1 derivative) of biote Corp. (BTMD) at $2.34 Transaction Date: Jun 08, 2026 | Filing ID: 000004
Read moreBiote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO
Read moreHEYER ANDREW R 🟢 acquired 165.3K shares (2 derivative) of biote Corp. (BTMD) at $2.20 Transaction Date: May 12, 2026 | Filing ID: 000002
Read moreMORRIS DEBRA L 🟡 adjusted position in 169.0K shares (3 derivative) of biote Corp. (BTMD) at $2.20 Transaction Date: May 12, 2026 | Filing ID: 000001
Read more